Secretory morphology of the intermediate lobe of the rat pituitary incubated in vitro

1988 ◽  
Vol 251 (3) ◽  
pp. 503-509 ◽  
Author(s):  
N. B�ck ◽  
K. Salminen ◽  
T. Laatikainen
Keyword(s):  
Intermediate Lobe ◽  
Rat Pituitary

Inhibition by prostaglandin E2of the release of vasopressin and β-endorphin from rat pituitary neurointermediate lobe or medial basal hypothalamus in vitro

1985 ◽  
Vol 106 (2) ◽  
pp. 189-195 ◽  
Author(s):  
W. Knepel ◽  
D. Nutto ◽  
M. Vlaskovska ◽  
Ch. Kittel
Keyword(s):  
Direct Action ◽  
Effective Concentration ◽  
Neurosecretory System ◽  
Intermediate Lobe ◽  
Medial Basal Hypothalamus ◽  
Neurointermediate Lobe ◽  
Rat Pituitary ◽  
Prostaglandin F ◽  
Spontaneous Secretion

ABSTRACT The present study was performed to examine the effect of the cyclo-oxygenase inhibitor, indomethacin, and that of various prostaglandins on the release of vasopressin and β-endorphin-like immunoreactivity (β-EI) from the rat neurointermediate lobe of the hypophysis, which was superfused in vitro. Indomethacin (2·8 and 28 μmol/l) changed neither basal secretion of vasopressin nor that evoked by electrical stimulation, whereas the resting release of β-EI was enhanced by indomethacin (28 μmol/l). Prostaglandin (PG) E2 did not influence resting release of vasopressin but markedly inhibited (by about 50%) electrically induced release of vasopressin (least effective concentration: 300 nmol/l) as well as spontaneous secretion of β-EI (least effective concentration: 100 nmol/l) in the presence of indomethacin (28 μmol/l). Prostaglandin F2α (5 μmol/l) also inhibited the evoked release of vasopressin, whereas PGD2 (5 μmol/l) did not. Prostaglandin F2α (5 μmol/l), D2 and I2 (1·5 μmol/l each) produced no effects on β-EI release. As observed in the neurohypophysis, PGE2 inhibited the electrically induced release of vasopressin from the medial basal hypothalamus in vitro. We conclude that prostaglandins (especially PGE2) can inhibit (1) the stimulated release of vasopressin when acting on vasopressin-containing nerve terminals of either neurosecretory system (neurohypophysis, median eminence region), and (2) the secretion of β-EI and, as can be inferred, α-MSH, by a direct action on intermediate lobe cells. J. Endocr. (1985) 106, 189–195

ABILITY OF VARIOUS FACTORS TO OPPOSE THE STIMULATORY EFFECT OF DIBUTYRYL CYCLIC AMP ON THE RELEASE OF MELANOCYTE-STIMULATING HORMONE BY THE RAT PITUITARY IN VITRO

1976 ◽  
Vol 68 (2) ◽  
pp. 283-287 ◽  
Author(s):  
BRIDGET I. BAKER
Keyword(s):  
Cyclic Amp ◽  
Cyclic Gmp ◽  
Inhibitory Effect ◽  
Aminobutyric Acid ◽  
Intermediate Lobe ◽  
Dibutyryl Cyclic Amp ◽  
Melanocyte Stimulating Hormone ◽  
Rat Pituitary ◽  
Stimulating Hormone

SUMMARY Various agents were tested for their ability to oppose the stimulatory effect of dibutyryl cyclic AMP on the release of the melanocyte-stimulating hormone from the rat neuro-intermediate lobe in vitro. Only dopamine exhibited an inhibitory effect; serotonin, γ-aminobutyric acid, tocinoic acid, tocinamide, the tripeptide Pro-Leu-Gly-NH2 and dibutyryl cyclic GMP were all ineffective.

Beta-adrenergic stimulation of the release of ACTH- and LPH-related peptides from the pars intermedia of the rat pituitary gland

1981 ◽  
Vol 97 (3) ◽  
pp. 343-351 ◽  
Author(s):  
F.J. H. Tilders ◽  
M. Post ◽  
S. Jackson ◽  
P.J. Lowry ◽  
P. G. Smelik
Keyword(s):  
Pituitary Gland ◽  
Cortical Cell ◽  
Pars Intermedia ◽  
Intermediate Lobe ◽  
Spontaneous Release ◽  
Adrenergic Stimulation ◽  
Similar Time ◽  
In Vitro Superfusion ◽  
Rat Pituitary

Abstract. The intermediate lobe of the rat pituitary gland produces a series of peptides related to ACTH and LPH. The spontaneous and isoproterenol-stimulated release of such peptides was studied during in vitro superfusion of rat neurointermediate lobes with Krebs-Ringer medium. Products released into the superfusion medium were quantified by direct measurement or after chromatography on Sephadex G-50. ACTH bioactivity was determined by use of adrenal cortical cell suspension assay. In addition, NH2-terminal ACTH, CO2H-terminal ACTH, α-MSH and β-endorphin radioimmunoassays were used. The results show that 1. neurointermediate lobes of rats secrete spontaneously various ACTH- and LPH-related peptides in amounts proportional to the amounts in which these peptides are found in extracts of the neurointermediate lobe; 2. the β-adrenergic agonist, isoproterenol, stimulated the spontaneous release of various peptides, including α-MSH, ACTH, CLIP, glycosylated CLIP, and β-endorphin-like peptides; 3. isoproterenol induced a dose-dependent (10−9–10−7 m), parallel increase in the release of α-MSH and ACTH following similar time courses and showing indentical EC50 values (about 10−8 m). Although the spontaneous release of α-MSH and ACTH from rat neurointermediate lobes is not strictly coupled under the conditions used in this study, isoproterenol seems to affect the spontaneous release of these peptides to the same relative extent.

Control of Bioactive Corticotropin Release from the Neuro-Intermediate Lobe of the Rat Pituitary in Vitro

Endocrinology ◽  
1977 ◽  
Vol 100 (4) ◽  
pp. 1047-1054
Author(s):  
Jerry L. Fischer ◽  
C. Michael Moriarty
Keyword(s):  
Intermediate Lobe ◽  
Rat Pituitary

The failure of L-prolyl-L-leucylglycinamide to inhibit the release of α-melanocyte-stimulating hormone in the rat

1980 ◽  
Vol 93 (3) ◽  
pp. 300-305 ◽  
Author(s):  
A. J. Thody ◽  
C. H. Lever de Vries ◽  
F. J. H. Tilders
Keyword(s):  
Dose Range ◽  
Female Rats ◽  
Inhibitory Influence ◽  
Intermediate Lobe ◽  
Intact Male ◽  
Melanocyte Stimulating Hormone ◽  
Male And Female Rats ◽  
Rat Pituitary

Abstract. We have studied the effect of L-prolyl-L-leucylglycinamide (PLG) on the release of melanocytestimulating hormone (MSH) from the rat pituitary gland both in vitro and in vivo. Superfusion of neurointermediate lobes with medium containing PLG or PLG-acetate (dose range 1–1000 ng/ml) did not affect the spontaneous release of MSH as determined by radioimmunoassay or by bioassay. Also during static incubations of rat hemipituitaries, PLG (6.6–50 ng/ml) was without effect on α-MSH release. Administration of PLG (1–250 ng iv) to intact male and female rats and rats bearing lesions in the medio-basal hypothalamus did not induce a fall in serum α-MSH levels. It is concluded that PLG does not affect the release of α-MSH from the rat intermediate lobe. It is unlikely therefore that PLG mediates the inhibitory influence of the CNS on MSH release.

INCORPORATION OF 14C-LABELLED AMINO ACIDS INTO CORTICOTROPHIN-LIKE INTERMEDIATE LOBE PEPTIDE AND α-MELANOCYTE-STIMULATING HORMONE BY THE RAT PITUITARY NEUROINTERMEDIATE LOBE IN VITRO, AND THE IDENTIFICATION OF FOUR NEW PARS INTERMEDIA PEPTIDES

1976 ◽  
Vol 70 (2) ◽  
pp. 197-205 ◽  
Author(s):  
A. P. SCOTT ◽  
P. J. LOWRY ◽  
TJ. B. VAN WIMERSMA GREIDANUS
Keyword(s):  
Amino Acids ◽  
The Other ◽  
Pars Intermedia ◽  
Intermediate Lobe ◽  
Melanocyte Stimulating Hormone ◽  
Neurointermediate Lobe ◽  
Rat Pituitary ◽  
Stimulating Hormone

SUMMARY At least seven radioactive peptides, which fractionated on Biogel P6, were found in rat neurointermediate lobes after incubation for 6 h with [14C]proline. Only three of these could be tentatively identified; one as α-melanocyte-stimulating hormone (α-MSH) and two as forms of corticotrophin-like intermediate lobe peptide (CLIP). One other crossreacted partially with a β-melanocyte-stimulating hormone (β-MSH) antiserum, was acidically charged and eluted on Biogel P6 in roughly the same position as ACTH. The other three peptides showed no resemblance to α-MSH, CLIP, β-MSH or ACTH.

Modulation of prolactin secretion by contraceptive progestins in cultured rat pituitary cells in vitro

1988 ◽  
Vol 117 (4_Suppl) ◽  
pp. S188-S189
Author(s):  
L. KIESEL ◽  
T. RABE ◽  
D. SCHOLZ ◽  
V. KIRSCHNER ◽  
B. RUNNEBAUM
Keyword(s):  
Prolactin Secretion ◽  
Pituitary Cells ◽  
Rat Pituitary ◽  
Rat Pituitary Cells
Sign in / Sign up

Export Citation Format

Share Document